Chemosensitization of Androgen-Independent Prostate Cancer with Neutral Endopeptidase

Clinical Cancer Research

Volumn 10, Issue 1 I, 2004, Pages 260-266

  Sumitomo, Makoto ^a   Asano, Tomohiko ^a   Asakuma, Junichi ^a   Asano, Takako ^a   Nanus, David M ^b   Hayakawa, Masamichi ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANTINEOPLASTIC AGENT; CASPASE 9; CGS 24592; CYTOCHROME C; ENKEPHALINASE INHIBITOR; ETOPOSIDE; LIPOCORTIN 5; MEMBRANE METALLOENDOPEPTIDASE; PACLITAXEL; PROTEIN KINASE C; PROTEIN KINASE C DELTA; ROTTLERIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TOXICITY; WESTERN BLOTTING;

ANDROGENS; ANNEXIN A5; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELLS, CULTURED; DRUG RESISTANCE, NEOPLASM; EPITHELIAL CELLS; ETOPOSIDE; HUMANS; MALE; MITOCHONDRIA; NEOPLASMS, HORMONE-DEPENDENT; NEPRILYSIN; PHENYLALANINE; PHOSPHONIC ACIDS; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; RECOMBINANT PROTEINS;

EID: 1642535484     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-0798-3     Document Type: Article

References (30)

1. Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., and Thun, M. J. Cancer statistics. 2003. CA. Cancer J. Clin., 53: 5-26, 2003.
2. Mahler, C., and Denis, L. Management of relapsing disease in prostate cancer. Cancer (Phila.), 70: 329-334, 1992.
3. Teicher, B. A., Kakeji, Y., Ara, G., Herbst, R. S., and Northey, D. Prostate carcinoma response to cytotoxic therapy: in vivo resistance. In Vivo, 11: 453-461, 1997.
4. Boesen-de Cock, J. G., Tepper, A. D., de Vries, E., van Blitterswijk, W. J., and Borst, J. Common regulation of apoptosis signaling induced by CD95 and the DNA-damaging stimuli etoposide and γ-radiation downstream from caspase-8 activation. J. Biol. Chem., 274: 14255-14261, 1999.
5. Sumitomo, M., Ohba, M., Asakuma, J., Asano, T., Kuroki, T., and Hayakawa, M. Protein kinase Cδ amplifies ceramide formation via mitochondrial signaling in prostate cancer cells. J. Clin. Investig., 109: 827-836, 2002.
6. Uslu, R., Sanli, U. A., Sezgin, C., Karabulut, B., Terzioglu, E., Omay, S. B., and Goker, E. Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines. Clin. Cancer Res., 6: 4957-4964, 2000.
7. Lebedeva, I., Rando, R., Ojwang, J., Cossum, P., and Stein, C. A. Bcl-xL in prostate cancer cells: effects of overexpression and downregulation on chemosensitivity. Cancer Res., 60: 6052-6060, 2000.
8. Smith, P. C., and Keller, E. T. Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice. Prostate, 48: 47-53, 2001.
9. Uemura, H., and Chang, C. Antisense TR3 orphan receptor can increase prostate cancer cell viability with etoposide treatment. Endocrinology, 139: 2329-2334, 1998.
10. Guo, C., Yu, S., Davis, A. T., Wang, H., Green, J. E., and Ahmed, K. A potential role of nuclear matrix-associated protein kinase CK2 in protection against drug-induced apoptosis in cancer cells. J. Biol. Chem., 276: 5992-5999, 2001.
11. Papandreou, C. N., Usmani, B., Geng, Y., Bogenrieder, T., Freeman, R., Wilk, S., Finstad, C. L., Reuter, V. E., Powell, C. T., Scheinberg, D., Magill, C., Scher, H. I., Albino, A. P., and Nanus, D. M. Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nat. Med., 4: 50-57, 1998.
12. Sumitomo, M., Shen, R., Goldberg, J. S., Dai, J., Navarro, D., and Nanus, D. M. Neutral endopeptidase promotes phorbol ester-induced apoptosis in prostate cancer cells by inhibiting neuropeptide-induced protein kinase Cδ degradation. Cancer Res., 60: 6590-6596, 2000.
13. Majumder, P. K., Pandey, P., Sun, X., Cheng, K., Datta, R., Saxena, S., Kharbanda, S., and Kufe, D. Mitochondrial translocation of protein kinase Cδ in phorbol ester-induced cytochrome c release and apoptosis. J. Biol. Chem., 275: 21793-21796, 2000.
14. Matassa, A. A., Carpenter, L., Biden, T. J., Humphries, M. J., and Reyland, M. E. PKCδ is required for mitochondrial-dependent apoptosis in salivary epithelial cells. J. Biol. Chem., 276: 29719-29728, 2001.
15. Sumitomo, M., Shen, R., Walburg, M., Dai, J., Geng, Y., Navarro, D., Boileau, G., Papandreou, C. N., Giancotti, F. G., Knudsen, B., and Nanus, D. M. Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling. J. Clin. Investig., 106: 1399-1407, 2000.
16. Lu, Z., Hornia, A., Jiang, Y. W., Zang, Q., Ohno, S., and Foster, D. A. Tumor promotion by depleting cells of protein kinase Cδ. Mol. Cell. Biol., 17: 3418-3428, 1997.
17. Blake, R. A., Garcia-Paramio, P., Parker, P. J., and Courtneidge, S. A. Src promotes PKCδ degradation. Cell Growth Differ., 10: 231-241, 1999.
18. Freedland, S. J., Seligson, D. B., Liu, A. Y., Pantuck, A. J., Paik, S. H., Horvath, S., Wieder, J. A., Zisman, A., Nguyen, D., Tso, C. L., Palotie, A. V., and Belldegrun, A. S. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer. Prostate, 55: 71-80, 2003.
19. Dai, J., Shen, R., Sumitomo, M., Goldberg, J. S., Geng, Y., Navarro, D., Xu, S., Koutcher, J. A., Garzotto, M., Powell, C. T., and Nanus, D. M. Tumor-suppressive effects of neutral endopeptidase in androgen-independent prostate cancer cells. Clin. Cancer Res., 7: 1370-1377, 2001.
20. Li, L., Lorenzo, P. S., Bogi, K., Blumberg, P. M., and Yuspa, S. H. Protein kinase Cδ targets mitochondria, alters mitochondrial membrane potential, and induces apoptosis in normal and neoplastic keratinocytes when overexpressed by an adenoviral vector. Mol. Cell. Biol., 19: 8547-8558, 1999.
21. Shichiri, M., Sedivy, J. M., Marumo, F., and Hirata, Y. Endothelin-1 is a potent survival factor for c-Myc-dependent apoptosis. Mol. Endocrinol., 12: 172-180, 1998.
22. Eberl, L. P., Valdenaire, O., Saintgiorgio, V., Jeannin, J. F., and Juillerat-Jeanneret, L. Endothelin receptor blockade potentiates FasL-induced apoptosis in rat colon carcinoma cells. Int. J. Cancer, 86: 182-187, 2000.
23. Prenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., and Ullrich, A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature (Lond.), 402: 884-888, 1999.
24. Sumitomo, M., Milowsky, M. I., Shen, R., Navarro, D., Dai, J., Asano, T., Hayakawa, M., and Nanus, D. M. Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor-Akt cell survival pathway. Cancer Res., 61: 3294-3298, 2001.
25. Clerk, A., and Sugden, P. H. Activation of protein kinase cascades in the heart by hypertrophic G protein-coupled receptor agonists. Am. J. Cardiol., 83: 64H-69H, 1999.
26. Murga, C., Laguinge, L., Wetzker, R., Cuadrado, A., and Gutkind, J. S. Activation of Akt/protein kinase B by G protein-coupled receptors. A role for α and βγ subunits of heterotrimeric G proteins acting through phosphatidylinositol-3-OH kinase γ. J. Biol. Chem., 273: 19080-19085, 1998.
27. Salido, M., Vilches, J., and Lopez, A. Neuropeptides bombesin and calcitonin induce resistance to etoposide induced apoptosis in prostate cancer cell lines. Histol. Histopathol., 15: 729-738, 2000.
28. Usmani, B. A., Shen, R., Janeczko, M., Papandreou, C. N., Lee, W. H., Nelson, W. G., Nelson, J. B., and Nanus, D. M. Methylation of the neutral endopeptidase gene promoter in human prostate cancers. Clin. Cancer Res., 6: 1664-1670, 2000.
29. Denning, M. F., Wang, Y., Tibudan, S., Alkan, S., Nickoloff, B. J., and Qin, J. Z. Caspase activation and disruption of mitochondrial membrane potential during UV radiation-induced apoptosis of human keratinocytes requires activation of protein kinase C. Cell Death Differ., 9: 40-52, 2002.
30. 2-M arrest. Cell Growth Differ., 13: 237-246, 2002.